Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Revenue

In the year 2023, Fennec Pharmaceuticals had annual revenue of $21.25M with 1,284.50% growth. Revenue in the quarter ending December 31, 2023 was $9.74M with 534.20% year-over-year growth.

• Revenue (ttm): $21.25M
• Revenue Growth: +1,284.50%
• P/S Ratio: 11.59
• Revenue / Employee: $732,828
• Employees: 29
• Market Cap: 246.34M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	21.25M	19.72M	1,284.50%
Dec 31, 2022	1.54M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	170.00K	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-
Dec 31, 2006	0	-	-
Dec 31, 2005	0	-	-
Jun 30, 2004	0	-	-
Jun 30, 2003	0	-	-
Jun 30, 2002	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.